サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1750670

構造的心臓閉塞装置の世界市場：市場規模・シェア・動向分析 (種類別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

Structural Heart Occlusion Devices Market Size, Share & Trends Analysis Report By Type (Left Atrial Appendage Occlusion Devices, Atrial Septal Defect Occluders), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 140 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
構造的心臓閉塞装置の世界市場：市場規模・シェア・動向分析 (種類別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)
出版日: 2025年05月02日
発行: Grand View Research
ページ情報: 英文 140 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場規模と動向：

世界の構造的心臓閉塞装置の市場規模は2024年に40億米ドルと推定され、2025年から2030年にかけてCAGR 7.0％で成長すると予測されます。

構造的心臓閉塞装置市場は、構造的心臓疾患の負担の増加、低侵襲治療の受け入れの増加、有利な規制と償還の変更により進展しています。臨床意識の高まりと手技の革新が対象患者を拡大し、力強いプラス成長の見通しを強めています。

構造的心臓疾患の有病率の増加は、構造的心臓閉塞装置市場の主要な促進要因です。心房中隔欠損症、卵円孔開存症、左心房付属器異常などの疾患は、診断技術が進歩し続けるにつれて臨床的な関心が高まっています。米国心臓協会の2024年統計更新では、米国における心房細動（AF）の有病率は2010年の約520万人から2030年には1,210万人に増加すると予測されており、効果的な介入に対する臨床的ニーズが高まっていることが強調されています。認知度が向上し、診断経路が標準化されるにつれて、閉塞療法に対応可能な患者層は大幅に拡大し、市場成長の強力な基盤が形成されます。

心房細動（AF）の有病率が世界的に上昇を続けるなか、左心房付属器閉塞術（LAAO）は構造的心臓閉塞装置市場において牽引役となっています。LAAOは、非弁膜症性心房細動患者、特に出血リスクの高い患者の脳卒中予防に、経口抗凝固薬に代わる非薬物療法を提供します。2025年2月にEuropean Heart Journal Supplementsに掲載された論文では、長期経口抗凝固療法（OAT）が禁忌の患者に対するLAAOの採用が増加していることに焦点が当てられています。この論文では、脳卒中予防におけるOATの役割にもかかわらず、特定の患者、特に出血性イベントの既往のある患者は虚血性脳卒中のリスクが高いままであることが強調されています。

規制と償還のイニシアチブは、構造的心臓閉塞装置市場の形成においてますます重要な役割を果たしています。臨床導入を促進し、技術革新への投資を促進し、先進治療への患者アクセスを拡大するためには、有利な政策環境が不可欠です。2025年3月、メディケア＆メディケイドサービスセンター（CMS）は、LAmbre Plus左心房付属器閉鎖システムを評価するREDUCE-AF臨床試験をCED（Coverage with Evidence Development）の下で承認しました。この決定は、非弁膜症性心房細動患者における機器の使用を支持する強固な臨床的エビデンスを構築することに規制当局が引き続き重点を置いていることを反映しています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 構造的心臓閉塞装置市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 構造的心臓閉塞装置市場：分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析

第4章 構造的心臓閉塞装置市場：種類別の推定・動向分析

  • 構造的心臓閉塞装置市場：種類別のダッシュボード
  • 構造的心臓閉塞装置市場：種類別の変動分析
  • 構造的心臓閉塞装置市場：市場規模の予測と動向分析、種類別 (2018～2030年)
  • 左心耳（LAA）閉塞装置
  • 心房中隔欠損（ASD）閉塞装置
  • 動脈管開存症（PDA）閉塞装置
  • その他

第5章 構造的心臓閉塞装置市場：最終用途別の推定・動向分析

  • 構造的心臓閉塞装置市場：最終用途別のダッシュボード
  • 構造的心臓閉塞装置市場：最終用途別の変動分析
  • 構造的心臓閉塞装置市場：市場規模の予測と動向分析、最終用途別 (2018～2030年)
  • 病院
  • 専門クリニック
  • 学術研究機関

第6章 構造的心臓閉塞装置市場：地域別の推定・動向分析（国別・種類別・適応症別・最終用途別）

  • 世界の構造的心臓閉塞装置市場：地域別のダッシュボード
  • 市場規模の予測と動向分析（2018～2030年）
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 最近動向と影響分析：主要メーカー別
  • 企業/競合の分類
  • 主要企業の市場シェア分析（2024年）
    • アボット
    • ボストン・サイエンティフィック・コーポレーション
    • オクルテック
    • ライフテックサイエンティフィック
    • メドトロニック
    • WLゴア＆アソシエイツ
    • レプ・メディカル・テクノロジー（北京）株式会社
    • エムツリーメディカル（カルディア株式会社）
    • バイオセンス・ウェブスター（ジョンソン・エンド・ジョンソン）
    • PFMメディカル社
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global structural heart occlusion devices market, by type 2018 - 2030 (USD Million)
  • Table 4 Global structural heart occlusion devices market, by end use, 2018 - 2030
  • Table 5 Global structural heart occlusion devices market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 9 U.S structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 10 U.S structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 14 Mexico structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 17 Europe structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 18 UK structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 19 UK structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 23 France structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Italy structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 25 Italy structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Spain structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 27 Spain structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Denmark structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 29 Denmark structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Sweden structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 31 Sweden structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Norway structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 33 Norway structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Japan structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 38 Japan structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 39 China structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 40 China structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 41 India structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 42 India structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Australia structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 44 Australia structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 45 Australia structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Thailand structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 47 Thailand structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 48 South Korea structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 49 South Korea structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Latin America structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 51 Latin America structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 52 Latin America structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Brazil structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 54 Brazil structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Argentina structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 56 Argentina structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 57 MEA structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 58 MEA structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 59 MEA structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Africa structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Africa structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 64 UAE structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 65 UAE structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Kuwait structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 67 Kuwait structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Participant's overview
  • Table 69 Financial performance
  • Table 70 Key companies undergoing expansions
  • Table 71 Key companies undergoing acquisitions
  • Table 72 Key companies undergoing collaborations
  • Table 73 Key companies launching new products
  • Table 74 Key companies undergoing partnerships
  • Table 75 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Structural heart occlusion devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Structural heart occlusion devices market revenues, 2024 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Structural heart occlusion devices market Type outlook:
  • Fig. 14 Structural heart occlusion devices market: Type movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global left atrial appendage (LAA) occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 17 Global atrial septal defect (ASD) occluders market, 2018 - 2030 (USD Million)
  • Fig. 18 Global patent ductus arteriosus (PDA) occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 19 Global others market, 2018 - 2030 (USD Million)
  • Fig. 20 Structural heart occlusion devices market end use outlook:
  • Fig. 21 Structural heart occlusion devices market: end use movement analysis
  • Fig. 22 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 23 Global specialty clinics market, 2018 - 2030 (USD Million)
  • Fig. 24 Global academic and research institutes market, 2018 - 2030 (USD Million)
  • Fig. 25 Regional market place: Key takeaways
  • Fig. 26 North America structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Canada structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 29 Mexico structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 30 Europe structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 31 Germany structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 32 UK structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 33 France structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Italy structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Spain structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Norway structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 40 Japan structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 41 China structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 42 India structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Australia structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 49 MEA structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 54 Market Participant Categorization
  • Fig. 55 Strategy mapping
目次
Product Code: GVR-4-68040-566-5

Market Size & Trends:

The global structural heart occlusion devices market size was estimated at USD 4.0 billion in 2024 and is projected to grow at a CAGR of 7.0% from 2025 to 2030. The structural heart occlusion devices market is advancing due to the rising burden of structural heart diseases, increasing acceptance of minimally invasive therapies, and favorable regulatory and reimbursement changes. Growing clinical awareness and procedural innovations are expanding the eligible patient pool, reinforcing a strong positive growth outlook.

The increasing prevalence of structural heart diseases is a major driver for the structural heart occlusion devices market. Conditions such as atrial septal defects, patent foramen ovale, and left atrial appendage abnormalities are gaining greater clinical attention as diagnostic technologies continue to advance. The American Heart Association's 2024 Statistical Update projects that the prevalence of atrial fibrillation (AF) in the U.S. will rise from approximately 5.2 million in 2010 to 12.1 million by 2030, underscoring the growing clinical need for effective interventions. As awareness improves and diagnostic pathways become more standardized, the addressable patient population for occlusion therapies is expanding significantly, creating a strong foundation for market growth.

As the prevalence of atrial fibrillation (AF) continues to rise globally, Left Atrial Appendage Occlusion (LAAO) procedures are gaining traction within the Structural Heart Occlusion Devices market. LAAO offers a non-pharmacologic alternative to oral anticoagulants for stroke prevention in patients with non-valvular AF, particularly those at high bleeding risk. A February 2025 article published in the European Heart Journal Supplements focused on the growing adoption of LAAO for patients with contraindications to long-term oral anticoagulant therapy (OAT). The article emphasizes that despite OAT's role in stroke prevention, certain patients, especially those with a history of bleeding events, remain at high risk for ischemic strokes.

Regulatory and reimbursement initiatives are playing an increasingly important role in shaping the structural heart occlusion devices market. Favorable policy environments are essential to encourage clinical adoption, promote investment in innovation, and expand patient access to advanced therapies. In March 2025, the Centers for Medicare & Medicaid Services (CMS) approved the REDUCE-AF clinical trial under Coverage with Evidence Development (CED) to evaluate the LAmbre Plus Left Atrial Appendage Closure System. This decision reflects continued regulatory emphasis on building robust clinical evidence to support device utilization in patients with non-valvular atrial fibrillation.

Global Structural Heart Occlusion Devices Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global structural heart occlusion devices market report based on type, end-use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Left Atrial Appendage (LAA) Occlusion Devices
  • Atrial Septal Defect (ASD) Occluders
  • Patent Ductus Arteriosus (PDA) Occlusion Devices
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Specialty clinics
  • Academic and Research Institutes
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Segment
    • 2.2.2. End Use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Structural Heart Occlusion Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of structural heart diseases
      • 3.2.1.2. Growth of minimally invasive cardiac interventions
      • 3.2.1.3. Regulatory and reimbursement tailwinds
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Regulatory approval delays
  • 3.3. Structural Heart Occlusion Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Structural Heart Occlusion Devices Market: Type Estimates & Trend Analysis

  • 4.1. Structural Heart Occlusion Devices Market: Type Dashboard
  • 4.2. Structural Heart Occlusion Devices Market: Type Movement Analysis
  • 4.3. Structural Heart Occlusion Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Left Atrial Appendage (LAA) Occlusion Devices
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Atrial Septal Defect (ASD) Occluders
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Patent Ductus Arteriosus (PDA) Occlusion Devices
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Structural Heart Occlusion Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Structural Heart Occlusion Devices Market: End Use Dashboard
  • 5.2. Structural Heart Occlusion Devices Market: End Use Movement Analysis
  • 5.3. Structural Heart Occlusion Devices Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Specialty Clinics
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Academic and Research Institutes
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Structural Heart Occlusion Devices Market: Regional Estimates & Trend Analysis by Country, Type, Indication, & End Use

  • 6.1. Global Structural Heart Occlusion Devices Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2024
    • 7.3.1. Abbott
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Boston Scientific Corporation
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Occlutech
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Lifetech Scientific
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Medtronic
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. W. L. Gore & Associates
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Lepu Medical Technology (Beijing)Co.,Ltd
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Emtree Medical (Cardia Inc.)
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Biosense Webster (Johnson & Johnson)
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. PFM Medical GMBH
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives